A carregar...

CD28z CARs and Armored CARs

CD19-targeted chimeric antigen receptor (CAR) T cells are currently being tested in the clinic with very promising outcomes. However, limitations to CAR T cell therapy exist. These include lack of efficacy against some tumors, specific targeting of tumor cells without affecting normal tissue and ret...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer J
Main Authors: Pegram, Hollie J., Park, Jae H., Brentjens, Renier J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4687893/
https://ncbi.nlm.nih.gov/pubmed/24667958
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0000000000000034
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!